SAD/MAD Safety and PK Study of RBN-3143 in Healthy and Atopic Dermatitis Subjects

NCT05215808 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
72
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Ribon Therapeutics, Inc.